Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,397Revenue $M0Net Margin (%)0Z-Score
Enterprise Value $M1,390EPS $0Operating Margin %0F-Score0
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)0Higher ROA y-yN
Price/Book010-y EBITDA Growth Rate %0Quick Ratio0Cash flow > EarningsN
Price/Sales05-y EBITDA Growth Rate %0Current Ratio0Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %ROA % (ttm)0Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M6.9ROI % (ttm)0Gross Margin Increase y-yN

Gurus Latest Trades with XBI

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

XBI is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!

XBI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Dion, JeanDirector 2015-03-06Buy10,000$0.1224620view
Bebek, IvanDirector 2015-03-06Buy500$1.4315614.69view
Laberge, Benoit10% Security Holder 2015-03-06Buy30,000$0.11204190.91view
Bromley, StevenSenior Officer 2015-03-05Buy423$9.942160.76view
Kendall, JeremyDirector, Senior Officer 2015-03-05Buy93$9.942160.76view
McKeracher, RobertSenior Officer 2015-03-05Buy448$9.942160.76view
Patel, Rakesh ThakorDirector or Senior Officer of Insider or Subsidiar 2015-03-05Sell5,000$181148.44view
Bouchard, MarioDirector, Senior Officer 2015-03-05Buy7,000$0.1224620view
Jones, III, Mark E.Director 2015-03-05Buy2,500$0.16140350view
Jones, III, Mark E.Director 2015-03-05Buy5,000$0.17132088.24view

Press Releases about XBI :

    Quarterly/Annual Reports about XBI:

      News about XBI:

      Articles On GuruFocus.com
      Are Earnings Important? These Days, Revenues Count for More! Mar 17 2014 

      More From Our Partners
      3 ETFs Surging at Start of 2015 - ETF News And Commentary Feb 27 2015 - ZACKS

      More From Other Websites
      Orexigen soars on drug data Mar 04 2015
      3 ETFs Surging at Start of 2015 - ETF News And Commentary Feb 27 2015
      The Best Biotech ETF Isn't Always The Biggest Feb 25 2015
      Trading tech & biotech: 8 plays on 2 hot sectors Feb 23 2015
      Who can beat the 'superbug'? Feb 19 2015
      Regulus joins the race to cure Hep C Feb 09 2015
      Biotechs Walking a Fine Line Feb 05 2015
      Best biotech plays Feb 04 2015
      Gilead Dislodges a Brick in the Biotech Wall of Worry Feb 04 2015
      Biotech Stocks Climb Wall of Worry in January Feb 02 2015
      Intercept absolutely a buy: Pro Jan 30 2015
      Reinventing pharma's next big frontier: Pro Jan 30 2015
      SPDR ETFs: Why Is State Street's Nick Good Excited About 2015? Jan 20 2015
      3 Sectors To Beat: Health, Tech and Industrials Jan 14 2015
      The Poster Child For Risk and Reward Jan 13 2015
      Allow Me To Introduce You To Jan 13 2015
      11 ways to play biotech Jan 12 2015
      Biotech dips mid-year, then you buy: Pro Dec 31 2014
      Best and worst performing ETFs this year Dec 29 2014
      Best & worst ETFs in 2014 Dec 29 2014

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      Free 7-day Trial